Ticker | Value | Shares | Price | Security | Type | Insider | Title | Return | Flags | Date |
|---|---|---|---|---|---|---|---|---|---|---|
| No transactions found | ||||||||||
Jarrad Mattieu Aguirre currently holds 19,857 shares of Lyell Immunopharma, Inc. (LYEL), valued at approximately $0. This represents their equity stake as Chief Medical Officer.
Based on SEC Form 4 filings, Jarrad Mattieu Aguirre has been a net seller of LYEL stock. They have purchased $0 and sold $3.6K worth of shares.
Jarrad Mattieu Aguirre's most recent insider trade was on Oct 12, 2026, when they sold 422 shares at $8.63 per share.
Jarrad Mattieu Aguirre serves as Chief Medical Officer at Lyell Immunopharma, Inc. (LYEL). They have executed 2 insider transactions totaling $3.6K over their tenure at the company.
Jarrad Mattieu Aguirre holds the position of Chief Medical Officer at Lyell Immunopharma, Inc., where they are responsible for executive-level decision-making and strategic oversight. They have been associated with the company for 1 years and currently hold a stake valued at $0.
Jarrad Mattieu Aguirre has shown a selling trading pattern, with $0 in total purchases and $3.6K in total sales across all transactions. Their most recent activity indicates a tendency to reduce their position.
The largest transaction by Jarrad Mattieu Aguirre was on Oct 12, 2026, when they sold $3.6K worth of LYEL shares. This transaction involved 422 shares at $8.63 per share.
Jarrad Mattieu Aguirre currently owns 19,857 shares of Lyell Immunopharma, Inc. (LYEL), with an estimated value of $0. This stake represents their equity holdings accumulated through purchases, awards, and option exercises.
All of Jarrad Mattieu Aguirre's SEC Form 4 insider trading filings are tracked on this page. Each transaction links directly to the official SEC EDGAR filing. Jarrad Mattieu Aguirre has 2 Form 4 filings on record as an insider at Lyell Immunopharma, Inc..
Set alerts for Jarrad Mattieu Aguirre and 40,000+ other insiders.